Religare Enterprises Limited approved the re-designation of Arjun Lamba as Managing Director during its August 12, 2026 board meeting. The company reported Q1 FY27 consolidated operational revenue of ₹2,353.4 crore and a net loss of ₹26.18 crore, while confirming the RBI did not accede to its demerger plan.
NEW DELHI — Religare Enterprises Limited (REL) approved the re-designation of Arjun Lamba as Managing Director on Wednesday, August 12, 2026, alongside releasing its financial results for the first quarter of FY27. The non-banking financial company reported a consolidated net loss of ₹26.18 crore (₹261.8 million) for the quarter ended June 30, 2026, alongside total consolidated revenue from operations of ₹2,353.4 crore (₹23.53 billion).
The decision was formalized during a meeting of the company’s Board of Directors following a recommendation from the Nomination & Remuneration Committee. The board's decisions signal ongoing organizational shifts as the financial services holding entity navigates corporate litigation and regulatory updates.
Leadership Reorganization and Governance Updates
Arjun Lamba, who has served as Executive Director since April 1, 2026, was re-designated as Managing Director effective August 12, 2026, subject to shareholder approval. Lamba’s tenure as Whole-time Director spans five years starting April 1, 2026, on terms and conditions that remain unchanged.
Lamba is the founder of Guardian Advisors Private Limited and brings over two decades of capital markets experience to the executive position. The company confirmed that Lamba holds no personal or familial relationships with other board members and is not debarred from capital market participation by the Securities and Exchange Board of India (SEBI) or any other authority.
In parallel, the board noted progress on an external governance review commissioned in FY25 to evaluate historical operating practices and internal controls across REL and its lending subsidiaries, Religare Finvest Limited (RFL) and Religare Housing Development Finance Corporation Limited (RHDFCL).
First Quarter FY27 Financial Breakdown
For the quarter ended June 30, 2026, Religare Enterprises reported total consolidated revenue from operations of ₹2,353.40 crore, compared to ₹1,871.52 crore in the corresponding period of the previous year. Consolidated total income stood at ₹2,358.43 crore. Total consolidated expenses reached ₹2,435.16 crore, driven primarily by operational costs in health insurance and employee benefit expenses.
On a standalone basis, REL recorded total income of ₹4.38 crore (₹438.17 lakhs) and a net loss after tax of ₹9.62 crore (₹961.97 lakhs).
The health insurance business, Care Health Insurance Limited (CHIL), generated gross written premium (GWP) income of ₹1,978.27 crore under Ind AS rules. Across its broader operating footprint, CHIL reported ₹3,247 crore in GWP under non-Ind AS accounting. During the quarter, REL invested ₹119.69 crore (₹11,968.52 lakhs) in CHIL through a rights issue.
In other divisions, Religare Broking Limited recorded total income of ₹99.5 crore and a profit after tax of ₹7.5 crore. Assets under custody in the broking business reached ₹47,946 crore as of June 30, 2026.
Regulatory Disclosures and Legal Contingencies
The financial disclosures highlighted several active regulatory and court proceedings:
Demerger Status: The Board previously approved a Scheme of Arrangement to demerge its financial services businesses—including lending, broking, and investments—into subsidiary Religare Finvest Limited. While stock exchanges BSE and NSE issued observation letters with no objections in July 2026, the Reserve Bank of India (RBI) communicated via letters dated August 6 and August 7, 2026, that the demerger application was not acceded to. REL and RFL stated plans to engage with the central bank to provide further details.
Capital Alterations: During the quarter, REL issued 8,343,263 equity shares following warrant conversions at ₹235 per share, raising ₹147.05 crore. Paid-up equity capital rose to ₹341.23 crore.
Tax Matters: The company faces pending Income Tax Appellate Tribunal (ITAT) appeals for Assessment Year 2017-18, involving a demand reduced by rectification order to ₹108.53 crore. ITAT granted an interim stay on recovery proceedings.
Dividend Restrictions: REL remains restricted from declaring dividends pursuant to an RBI communication dating to December 2019.
Official Statements
In official communications accompanying the filing, management commented on the firm's operational focus and balance sheet position.
"Q1 FY27 represents a quarter of deliberate, measured progress wherein we have chosen to build strong foundations over chasing short-term headlines," said Arjun Lamba, Managing Director of Religare Enterprises Limited. "We have deployed capital across the group, completed our leadership architecture, and elevated governance standards to institutional levels. Every business is well-capitalised and ready to scale."
Pratul Gupta, Chief Financial Officer, added: "Q1 FY27 demonstrates disciplined operational execution across our portfolio. CHIL achieved 37% GWP growth with improving performance metrics; RBL continues to maintain momentum despite market headwinds; RFL with strong focus on collections is prepared to restart the business with adequate capital."
Practical Impact
The leadership appointment provides executive continuity as REL resolves outstanding legal actions and regulatory interactions. Meanwhile, capital injections into Care Health Insurance and warrant conversions bolster liquidity for individual business lines. However, the RBI's decision regarding the proposed demerger delays the structural separation of insurance assets from the broader financial services portfolio.
Key Facts at a Glance
Executive Designation: Arjun Lamba re-designated as Managing Director for a 5-year term from April 1, 2026.
Financial Results: Consolidated revenue stood at ₹2,353.40 crore; consolidated net loss landed at ₹26.18 crore.
Insurance Performance: Care Health Insurance recorded ₹3,247 crore in GWP (pre-Ind AS) with ₹150 crore raised via rights issue.
Regulatory Update: RBI did not accede to the proposed demerger scheme into Religare Finvest.
Capital Raised: ₹147.05 crore received via conversion of 8.34 million warrants into equity.
Frequently Asked Questions
What was approved regarding Religare's leadership?
The board approved re-designating Arjun Lamba as Managing Director, subject to shareholder approval, maintaining the same terms and a five-year term effective April 1, 2026.
What were Religare's consolidated Q1 FY27 financial results?
Religare Enterprises reported consolidated total revenue from operations of ₹2,353.40 crore and a net loss of ₹26.18 crore for the quarter ended June 30, 2026.
What is the status of Religare's demerger scheme?
Although stock exchanges issued no-objection letters in July 2026, the RBI communicated in August 2026 that the application was not acceded to, prompting REL to engage in further discussions with the regulator.
Source: Official regulatory filings to the National Stock Exchange of India Ltd and BSE Limited, alongside statutory statements from Religare Enterprises Limited.
